Is customisation healthcare’s secret weapon?

<p><strong><span data-contrast="auto">Podcast: Is customisation healthcare’s secret weapon?</span></strong><span data-ccp-props= "{"201341983":0,"335551550":1,"335551620":1,"335559739":160,"335559740":259}"> </span></p> <p><span data-contrast="auto">This is the latest episode of the free DDW podcast, “</span><span data-contrast="none">Is customisation healthcare’s secret weapon?</span><span data-contrast="auto">”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW.</span><span data-ccp-props= "{"201341983":0,"335551550":1,"335551620":1,"335559739":160,"335559740":259}"> </span> <span data-contrast="auto">The articles are called “Optimising vaccine production through customisation” and “Exploring iPSCs for individual and population health applications”.</span><span data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> </span></p> <p><span data-contrast="none">In the first article, “Optimising vaccine production through customisation”, John Yoshi Shyu, Ph.D. Corning Life Sciences offers an expert view on the topic. In the second article, Brad Hamilton, Founder and Chief Science Officer at GoodCell, examines the potential of induced Pluripotent Stem Cells.</span><span data-ccp-props= "{"201341983":0,"335551550":1,"335551620":1,"335559739":160,"335559740":259}"> </span></p> <p><span data-contrast="auto">You can also find The Drug Discovery World Podcast on</span> <a href= "https://open.spotify.com/show/5HpeK1T3H1VQIB1fiwn0KQ"><span data-contrast="none"> Spotify</span></a><span data-contrast="auto">,</span> <a href= "https://play.google.com/store/apps/details?id=com.edify.ddw"><span data-contrast="none"> Google Play</span></a> <span data-contrast="auto">and</span> <a href= "https://apps.apple.com/gb/app/drug-discovery-world-ddw/id1530786395"> <span data-contrast="none">Apple Podcasts.</span></a><span data-ccp-props= "{"201341983":0,"335551550":1,"335551620":1,"335559739":160,"335559740":259}"> </span></p>